Bristlecone Advisors’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-220
Closed -$24.9K 265
2025
Q2
$24.9K Hold
220
﹤0.01% 267
2025
Q1
$22.7K Hold
220
﹤0.01% 332
2024
Q4
$24.8K Hold
220
﹤0.01% 326
2024
Q3
$25.2K Buy
+220
New +$24.5K ﹤0.01% 332
2023
Q2
Sell
-120
Closed -$10.7K 305
2023
Q1
$10.7K Buy
+120
New +$10.6K ﹤0.01% 326

Other funds holding IVOG

Bristlecone Advisors's IVOG Position: Q3 2025 in Review

Bristlecone Advisors sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q3 2025, closing a stake of 220 shares — an estimated $24.9K sold.

Bristlecone Advisors first reported a position in IVOG in Q1 2023 and held it in 5 quarters. The position peaked at $25.2K in Q3 2024. 157 funds tracked by Wall St. Rank hold IVOG as of Q3 2025.

  • Bristlecone Advisors reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q3 2025 after selling out during the quarter.
  • Bristlecone Advisors sold 220 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q3 2025, an estimated $24.9K.
  • Bristlecone Advisors first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q1 2023 and held it in 5 quarters.
  • Bristlecone Advisors's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $25.2K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q3 2025.

Based on Bristlecone Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.